Skip to content

William P. Quinn, President, CEO and CFO at Bolt Biotherapeutics, bought BOLT on Jun 5, 2026

Data as of Oct 16

▲ BUY$2.5K637 shares at $3.88William P. Quinn President, CEO and CFOBOLT Bolt Biotherapeutics, Inc.
Watch BOLT
Traded
Jun 5, 2026
Disclosed
Sep 21, 2026
Filed
108 days after the trade · late

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

William P. Quinn, President, CEO and CFO at Bolt Biotherapeutics, bought BOLT on Jun 5, 2026TRADEDDISCLOSED
BOLTSimilar stocks (XLV — its sector index fund), rebased to BOLT's price on the disclosure day
BOLT since disclosure
+11.4%
Similar stocks (XLV) since disclosure
+4.6%
XLV — its sector index fund

Change in closing price from Sep 21, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLWilliam P. Quinn President, CEO and CFOBOLT Bolt Biotherapeutics, Inc.$29.6Kdisclosed Sep 21 · filed 3 days after the trade
  2. ▼ SELLWilliam P. Quinn President, CEO and CFOBOLT Bolt Biotherapeutics, Inc.$21.7Kdisclosed Sep 21 · filed 4 days after the trade
  3. ▼ SELLWilliam P. Quinn President, CEO and CFOBOLT Bolt Biotherapeutics, Inc.$7.1Kdisclosed Sep 21 · filed 5 days after the trade · late

See every trade on BOLT →